Kefir {51111222} Record Keys Definition:Kefir Queue:[ ] Details Initialisation date:2021-07-16 Specification: [ ] Meta Information Type:Diet Host: Mouse Zone:[ ] Notes: [ ]Shared Reference Notes [1.1] - Kefir reduces repetitive behaviour and modulates immunity in a mouse model of ASD. - Kefir does not affect intestinal permeability. - Kefir increases Lachnospiraceae bacterium A2 and decreases Clostridiaceae abundance. - Kefir increases T regulatory cells in mesenteric lymph nodes. [1.2] [#Lactococcus raffinolactis] - kefir consumption in a healthy cohort can have a subtle impact on the urinal metabolome and gut microbiome in a subset of participants. - The principle change to the gut microbiome was the detection of Lc. raffinolactis. [1.3] [#Short Chain Fatty Acid] - kefir increased catalase and superoxide dismutase (colon), and SCFAs in feces (#Butyrate), and in the brain (#Butyrate and #Propionate). - Milk kefir had 76.64 ± 0.42% of free radical scavenging and the microbiota composed primarily by the genus #Comamonas. - Kefir reduced triglycerides, #Uric acid, and affected the microbiome of animals increasing fecal #Butyrate-producing bacteria (#Lachnospiraceae and #Lachnoclostridium). [1.4] - In KPs-pretreated (Kefir Peptide) bleomycin-induced lung fibrotic mice, notable outcomes included the absence of significant bodyweight loss, enhanced pulmonary functions, restored lung tissue architecture, and diminished thickening of inter-alveolar septa, as elucidated by morphological and histopathological analyses. - a reduction in the expression levels of oxidative biomarkers, inflammatory factors, and fibrotic indicators was observed. - KPs pretreatment induced alterations in the relative abundances of gut microbiota, notably affecting #Barnesiella intestinihominis, #Kineothrix alysoides, and #Clostridium viride.References Notes[ ]
